Fecal microbiota transplantation for irritable bowel syndrome: An intervention for the 21st century

Figure 10  Differences in signals for Lactobacillus spp. in the responder, nonresponder, and placebo groups between before and 1 mo after transplantation. There were significant changes in the signal levels in responders (P < 0.001). A: The nonresponders exhibited similar signal levels to those in the responders, while there was no change in the placebo group; B: The signal levels in the responder, nonresponder, and placebo groups were similar, but it was higher for the superdonor; C: After transplantation, the signal levels in responders and nonresponders became similar to that for the superdonor, while that in the placebo group did not differ from the baselin. Citation: El-Salhy M, Hatlebakk JG, Gilja OH, Bråthen Kristoffersen A, Hausken T. Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study. Gut 2020; 69: 859-867. Copyright @BMJ Publishing Group Ltd 2020. Published by BMJ Publishing Group Ltd[11].